Abstract
The present study was based in a hospital at which 660 individuals have been screened for thalassemia in the past 4 years. The main purposes of the study were to identify different types of beta mutations prevailing among these patients, and to establish a genotype–phenotypic correlation. Complete blood count, high-performance liquid chromatography, and amplification refractory mutation system-based polymerase chain reaction were performed on peripheral blood samples to detect beta mutations. Of the 660 subjects studied, 380 (57.6 %) were male and 280 (42.4 %) were female. These included 258 (39.09 %) normal individuals, 176 (26.67 %) β-thalassemia carriers, 44 (6.67 %) β-thalassemia major, 6 (0.91 %) cases of sickle β-thalassemia, 6 (0.91 %) carriers of sickle cell anemia, 102 (15.45 %) Hb Eβ-thalassemia, 42 (6.36 %) HbE carriers, 16 (2.42 %) HbE homozygous, and 10 (1.52 %) carriers of other mutations. Genotypic study of beta mutations revealed the prevalence of IVS1-5 mutation among the studied beta carriers to be 46.6 %, and codon 26 (G>A) mutation to be 31.54 %. Other prevailing mutations among the screened individuals include codon 30 (7.53 %), codon 15 (5.01 %), codon 41/42 (3.58 %), and codon 8/9 (1.07 %). Genotype–phenotype correlation revealed that the phenotype of the above-mentioned mutations is associated with mild, moderate, and severe forms of thalassemia.
Similar content being viewed by others
References
Weatherall DJ, Clegg JB. The thalassaemia syndromes. 4th ed. Oxford: Blackwell Science Ltd; 2001.
Christianson A, Howson CP, Modell B. March of Dimes:global report on birth defect. March of Dimes Birth Defects Foundation White Plains, New York 2006.
Mukherji M. Cooley’s anaemia (erythroblastic or mediterranean anaemia). Indian J Pediatr. 1938;5:1–7.
Weatherall DJ, Clegg JB. Thalassemia: a global public health problem. Nat Med. 1996;2(8):847–9.
Yaish HM. Thalassemia. http://www.emedicine.com/.PED/topic2229.htm. Accessed 6 Aug 2007.
Verma IC, Choudhury VP, Jain PK. Prevention of thalassemia: a necessity in India. Indian J Pediatr. 1992;59(6):649–54.
Weatherall DJ, Clegg JB. Inherited haemoglobin disorders: an increasing global health problem. Bull World Health Organ. 2001;79(8):704–12.
Marwah RK, Lal A. Present status of hemoglobinopathies in India. Indian Paediatr. 1994;31:267–71.
Jain V, Sachdeva A, Lokeshwar MR. Prevention of thalassemia. In: Sachdeva A, Lokeshwar MR, Shah N, Agarwal BR, editors. Hemoglobinopathies. New Delhi: Jaypee Brothers Publishers; 2006. p. 94–104.
Thein SL. Molecular Genetics of β Thalassaemia. XXVIth World Congress of the International Society of Haematology Singapore. Aug 1996; 25–9.
Kukreti R, Dash D, Ke V, Chakravarty S, Das S, De M, Talukdar G. Spectrum of β-thalassemia mutations and their association with allelic sequence polymorphisms at the beta globin gene cluster in an eastern Indian population. Am J Hemat. 2002;70(4):269–77.
Varawalla NY, Old JM, Sarkar R, Venkatesan R, Weatherall DJ. The spectrum of β-thalassemia mutations on the Indian subcontinent: the basis for prenatal diagnosis. Br J Haematol. 1991;78(2):242–7.
Chen S, Eldor A, Barshtein G, Zhang S, Goldfarb A, Rachmilewitz E, Yedgar S. Enhanced agreeability of red blood cells of beta-thalassemia major patients. Am J Physiol. 1996;270(6 Pt 2):1951–6.
de Silva S, Fisher CA, Premawardhena A, Lamabadusuriya SP, Peto TE, Perera G, Old JM, Clegg JB, Olivieri NF, Weatherall DJ. Thalassaemia in Sri Lanka: implications for the future health burden of Asian populations. Sri Lanka Thalassaemia Study Group. Lancet. 2000;355(9206):786–91.
Premawardhena A, De Silva S, Arambepola M, Olivieri N, Merson L, Muraco J, Allen A, Fisher C, Peto T, Vichinsky E, Weatherall DJ. Thalassemia in Sri Lanka: a progress report. Hum Mol Genet. 2004;13(2):203–6.
Vichinsky EP. Report of proceedings: 1999 international conference on E-β thalassaemia. J Pediatr Hematol Oncol. 2000;22(6):550.
Guidelines for the control of haemoglobin disorders. Report of the VIth Annual Meeting of the WHO Working Group on Haemoglobinopathies. Cagliari: World Health Organization; 1989.
Weatherall DJ. The role of the inherited disorders of hemoglobin, the first "molecular diseases", in the future of human genetics. Annu Rev Genomics Hum Genet. 2013;14:1–24.
Flint J, Harding RM, Boyce AJ, Clegg JB. The population genetics of the haemoglobinopathies. Baillieres Clin Haematol. 1998;11(1):1–51.
Old JM, Varawalla NY, Weatherall DJ. Rapid detection and prenatal diagnosis of beta-thalassaemia: studies in Indian and Cypriot populations in the UK. Lancet. 1990;336:834–7.
Craig JE, Barnetson RA, Prior J, Raven JL, Thein SL. Rapid detections of deletions causing δβ thalassemia and hereditary persistence of fetal hemoglobin by enzymatic amplifications. Blood. 1994;83(6):1673–82.
Ajmani M, Talukdar G, Sharma A, Bhattacharya DK. Expression of Hb β-T and Hb β-E genes in eastern India -Family studies. J Biosci. 1981;3(2):191–6.
Haig HK Jr, Corinne OB. Molecular basis and prenatal diagnosis of beta-thalassemia. Blood. 1988;72:1107–16.
Sen U, Dasgupta JL, Choudhury D, Datta P, Chakrabarti A, Chakrabarty SB, Chakrabarty A, Dattagupta JK. Crystal structures of HbA2 and HbE and modeling of hemoglobin δ4: interpretation of the thermal stability and the anti sickling effect of HbA2 and identification of the ferrocyanide binding site in Hb. Biochemistry. 2004;43(39):12477–88.
Orkin SH, Kazazian HH Jr, Antonarakis SE, Ostrer H, Goff SC, Sexton JP. Abnormal RNA processing due to the exon mutation of beta E-globin gene. Nature. 1982;300(5894):768–9.
Varawalla NY, Old JM, Weatherall DJ. Rare β-thalassemia mutations in Asian Indians. Br J Haematol. 1991;79(4):640–4.
Agarwal S, Hattori Y, Agarwal SS. Rare beta thalassemia mutations in Asian Indians. Am J Hematol. 2000;65(4):322–3.
Thein SL, Hesketh C, Wallace RB, Weatherall DJ. The molecular basis of thalassemia major and thalassemia intermedia in Asian Indians. Application to the prenatal diagnosis. Br J Hematol. 1988;70(2):225–31.
Panigrahi I, Marwah RK. Mutational spectrum of thalassemia in India. Indian J Hum Genet. 2007;13(1):36–7.
Kulozik AE, Bail S, Kar BC, Serjeant BE, Serjeant GE. Sickle cell β+ thalassemia in Orissa state, India. Br J Hematol. 1991;77(2):215–20.
Das S, De M, Bhattacharya DK, Sengupta B, Das N, Talukdar G. Interaction of different hemoglobinopathies in eastern India with a view to establish genotype-phenotype correlation. Am J Hum Bio. 2000;12(4):454–9.
Verma IC, Saxena R, Thomas E, Jain PK. Regional distribution of thalassemia mutation in India. Hum Genet. 1997;100(1):109–13.
Bandopadhayay A, Bandopadhyay S, Chowdhury MD, Dasgupta UB. Major beta globin gene mutations in Eastern India and their associated haplotypes. Hum Hered. 1999;49(4):232–5.
Agarwal S, Naveed M, Gupta UR, Kishor P, Agarwal SS. Characterization of beta thalassemia mutation in 57 beta thalassemia families seen at Lucknow. Indian J Med Res. 1994;100:106–10.
Madan N, Sharma S, Rusia U, Sen S, Sood SK. Beta thalassemia in Northern India (Delhi). Indian J Med Res. 1998;107:134–41.
Bhattacharyya D, Mukhopadhyay A, Chakraborty A, Dasgupta S, Mukhopadhyay S, Pal N, et al. Incidence of the HbE [β26(B8)Glu→Lys, GAG>AAG] variant in Totos, one of the smallest primitive tribes in the world. Hemoglobin. 2013;37(1):26–36.
Winichagoon P, Fucharoen S, Chen P, Wasi P. Genetic factors affecting clinical severity in beta thalassemia syndromes. J Pediatr Hematol Oncol. 2000;22(6):573–80.
Winichagoon P, Fucharoen S, Weatherall DJ, Wasi P. Concomitant inheritance of alpha thalassemia in beta 0-thalassemia/HbE disease. Am J Hematol. 1985;20(3):217–22.
Kihm AJ, Kong Y, Hong W, Russell JE, Rouda S, Adachi K, et al. An abundant erythroid protein that stabilizes free alpha hemoglobin. Nature. 2002;417:758–63.
Panigrahi I, Agarwal S, Gupta T, Singhal P, Pradhan M. Hemoglobin E-beta thalassemia: factors affecting phenotype. Indian Pediatr. 2005;42:357–62.
Bhattacharya G, Dasgupta U, Banerjee D, Chandra S, Das M, Ghosh M, Chaudhuri U. Molecular basis of deletional hereditary persistence of fetal hemoglobin and δβ-thalassemia in Indian patients. Clin Chim Acta. 2008;392(1):69–70.
Thein SL. Genetic modifiers of β-thalassemia. Hematologica. 2005;90(5):649–60.
Acknowledgments
We are grateful to all the individuals who participated in this study. We would like to thank Mrs. Nabamita Pal and Mr. Priyabrata Das for their extensive support and all other staff members of research department. We wish to acknowledge West Bengal University of Health Sciences, Kolkata, India to which the institute is affiliated.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Bhattacharyya, D.M., Mukhopadhyay, A. & Basak, J. Descriptive profile of β-thalassemia mutations in West Bengal population: a hospital-based study. Int J Hematol 99, 345–353 (2014). https://doi.org/10.1007/s12185-014-1511-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12185-014-1511-4